Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Renovis IncfiledCriticalRenovis Inc
Publication of ECSP088739ApublicationCriticalpatent/ECSP088739A/en
Se describen compuestos que tienen una formula representada por la siguiente: Formula ( I). Los compuestos pueden prepararse como composiciones farmacéuticas, y pueden usarse para la prevención y tratamiento de una diversidad de padecimientos en mamíferos incluyendo humanos, incluyendo a manera de ejemplo no limitante, dolor, inflamación, lesión traumática y otros.Compounds having a formula represented by the following are described: Formula (I). The compounds can be prepared as pharmaceutical compositions, and can be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, pain, inflammation, traumatic injury and others.
ECSP0887392006-02-232008-09-15
DERIVATIVES OF AMIDAS AS LIGANDOS OF ION CHANNELS AND PHARMACEUTICAL COMPOSITIONS AND METHODS TO USE THE SAME
ECSP088739A
(en)
Compounds derived from prostaglandin e2 inhibitor 2-arylamino-benzimidazoles (mpges-1); pharmaceutical composition that includes them; intermediary compounds; use in the treatment of inflammatory diseases and / or associated conditions, in particular pain.
Compounds derived from pyridin-4-yl-thiazol-2-amide 2-amide-pyrrolidin-1,2-dicarboxylic, phosphatidyl-inositol-3 kinase inhibitors; pharmaceutical composition comprising one of the compounds; and use of the compounds in the preparation of a medicament for the treatment of cancer.
Compounds derived from nitrogenous tricycles, with antibacterial activity; preparation procedure; pharmaceutical composition comprising them; for the treatment of tuberculosis.